ASTH astranahealth.com: Company Value to Revenue Ratio

Public company logo of astranahealth.com (ASTH)

An efficient clinic network ensures a seamless supply of medications, confirming the company's price-to-sales trend, where the parameter value reaches 454.14. Astrana Health, Inc. (ASTH) relies on government contracts and the expansion of physician partnerships. However, regulatory risks associated with Medicare, rising treatment costs, and challenges integrating new medical centers undermine this stability.

ASTH Astrana Corp Company Value to Revenue (11/23/2025 - 11/20/2026)

astranahealth.com - analytical breakdowns and key metrics (ASTH)

- current quotes and average value forecast:
Fundamental company valuation:ASTH - astranahealth.com
Product sample of Astrana Health, Inc.

The EV/Sales multiple measures the total value of the business (both equity and debt capital) relative to annual sales volume. It allows for the assessment of an asset's market value by excluding the impact of the debt structure. The trend of the enterprise value-to-revenue multiple reflects the efficiency of healthcare digitalization and the implementation of ESG standards at Astrana Health, Inc. (ASTH). The stability of this metric confirms the resilience of the patient coordination model. A growing trend signals that investors are revaluing the efficiency of operational processes.

Competitor analysis

Enterprise Value-to-Revenue Multiple hcahealthcare.com|THC: EV/Sales Multiple|FMS - Total Company Value-to-Revenue Ratio|Company Value to Revenue SOLV|Encompass (EHC) - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Universal Health Services, Inc. (UHS)|DaVita Inc. - Company Value to Revenue Ratio|Enterprise Value-to-Revenue Ratio RadNet Corp RDNT|EV/Sales Multiple Option Care OPCH|Surgery Partners Inc - EV/Sales Multiple|PINC (Premier Corp) - Company Value to Revenue Ratio|nationalvision.com (EYE) - Enterprise Value-to-Revenue Ratio|Company Value to Revenue Progyny|Company Value to Revenue ARDT|EV/Sales Multiple Select Medical Corporation|EV/Sales Multiple MD|Enterprise Value-to-Revenue Ratio USPH (US Physical Therapy Inc)|Enterprise Value-to-Revenue Ratio The Pennant Group, Inc. PNTG|Business Value to Revenue ORGO|NUTX - Enterprise Value-to-Revenue Ratio|AUNA - EV/Sales Multiple|SBC Medical Group Inc (SBC) - Enterprise Value-to-Revenue Ratio|EOLS: Enterprise Value-to-Revenue Coefficient|Enterprise Value-to-Revenue Ratio chs.net|SKIN: Business Value to Revenue|EV/Sales Multiple MDWD|BTMD - Enterprise Value-to-Revenue Multiple|The Joint Chiropractic - Company Value to Revenue|Enterprise Value-to-Revenue Coefficient DCGO (DocGo, Inc)|Total Company Value-to-Revenue Ratio PIII (p3hp.org)|GANX (Gain Therapeutics) - Company Value to Revenue Ratio|euda.com (EUDA) - Enterprise Value-to-Revenue Ratio|Company Value to Revenue Basel Medical|CLGN (CollPlant Biotechnologies) - EV/Sales Multiple|EV/Sales Multiple Cuprina Holdings Limited|Enterprise Value-to-Revenue Ratio concordmedical.com (CCM)|Enterprise Value-to-Revenue Ratio AMS (American Shared Hospital)|Enterprise Value-to-Revenue Ratio MEDIROM Corp MRM|EV/Sales Multiple avalon-globocare.com ALBT|DHAI - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Longevity Health Holdings XAGE|NIVF (NewGenIvf Group Limited) - Company Value to Revenue|ATI Physical Therapy Inc. - Business Value to Revenue|CMAX (caremax.com) - EV/Sales Multiple|KDLY (Kindly MD Inc) - Enterprise Value-to-Revenue Coefficient|Enterprise Value-to-Revenue Ratio ModivCare Corp (MODV)|Total Company Value-to-Revenue Ratio Novo Integrated Sciences|SunLink Health Systems, Inc. - Company Value to Revenue|imacholdings.comm (BACK) - Enterprise Value-to-Revenue Multiple